Blood Tests on a Steroid Cycle: 12 Key Markers & Reference Values

Blood Tests on a Steroid Cycle: 12 Key Markers & Reference Values

TL;DR- Test baseline bloods 2–4 weeks before any cycle begins.- Haematocrit above 54% demands immediate action — reduce dose or phlebotomise.- HDL below 35 mg/dL on oral compounds signals you should cut or stop the oral.- Interpret oestradiol symptomatically; target 20–40 pg/mL, not "as low as possible."- GGT is the most reliable liver marker on cycle — ALT and AST lie after hard training.- Four blood draws across a cycle provide a complete safety picture.

A steroid cycle blood panel is a structured set of biochemical markers used to detect cardiovascular, hepatic, haematological, and endocrine changes that anabolic-androgenic steroids produce before those changes become clinically symptomatic. Running a cycle without bloodwork is the physiological equivalent of driving a motorway at speed with no instruments — the most dangerous shifts in haematocrit, lipid ratios, and liver enzymes are completely invisible to subjective self-assessment. This guide details the 12 markers that genuinely matter, complete with male reference ranges, interpretation principles, and evidence-based action thresholds. Data draws on harm-reduction literature including Bonnecaze et al. (PMC, 2021) and current endocrinology standards, reviewed as of August 2026.

Why Routine Bloods Fail Cycle Monitoring

The standard "full blood count" your GP orders captures red and white cell morphology but omits the markers that steroids actually perturb. It contains no lipid fractions, no oestradiol, no GGT, and no gonadotropins — rendering it essentially useless for on-cycle monitoring. A purpose-built cycle panel draws from four physiological systems: haematology (haematocrit, haemoglobin), cardiovascular metabolism (HDL, LDL, triglycerides, fasting glucose), hepatology (ALT, AST, GGT), and the hypothalamic-pituitary-gonadal axis (total testosterone, oestradiol, LH, FSH, and prolactin where 19-nor compounds are involved).

Private preventive diagnostic labs across the UK offer self-pay panels covering all 12 markers; many sports medicine clinics will run identical panels on request. The investment across a full cycle — four draws — is modest compared to the cost of the compounds themselves, and it is the only mechanism capable of detecting damage before it becomes irreversible.

The 12 Markers: Reference Ranges and Action Thresholds

When to Test: Four Draws, Four Functions

Timing is as important as the marker selection itself. Each blood draw serves a distinct diagnostic purpose.

Baseline (2–4 weeks pre-cycle): Without a baseline, every on-cycle result is uninterpretable. You cannot define deviation without knowing the individual's starting point — a GGT of 55 U/L means something entirely different in someone whose baseline was 20 U/L versus someone whose baseline was 50 U/L.

Mid-cycle week 5–6: This is where lipid suppression, haematocrit elevation, and hepatic stress typically peak on most cycles. Long-ester protocols (testosterone enanthate, testosterone cypionate with their 4.5–8-day half-lives) are adequately reflected by week six. Short esters and orals should be checked closer to week five.

End of cycle: Confirms the cumulative picture before PCT begins. Haematocrit and liver enzymes are the priority here.

Recovery check, 4–6 weeks post-PCT: This is the draw most users skip and the one that matters most for long-term health. LH, FSH, total testosterone, and oestradiol together reveal whether the hypothalamic-pituitary axis has actually restored endogenous production. Gonadotropin-releasing hormone stimulation from the hypothalamus drives LH and FSH secretion; only when these are within range and testosterone has recovered can the axis be considered functional.

Why ALT and AST Mislead Trained Athletes

Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are textbook hepatic injury markers — but both enzymes are also expressed in significant concentrations in skeletal muscle tissue. Intense resistance training reliably elevates ALT 2–4 times above baseline and AST 3–6 times above baseline in natural athletes within 24 hours of a heavy session, entirely independent of liver status. This muscle-release artefact is well documented in sports medicine literature and makes ALT and AST unreliable in isolation for trained individuals on cycle.

Gamma-glutamyl transferase (GGT), by contrast, is predominantly hepatic in origin. GGT is induced by hepatocellular stress, alcohol, and hepatotoxic compounds — not by muscle damage. It is therefore the most honest single liver marker available on cycle. Bilirubin provides secondary confirmation. Practical protocol: avoid training 48–72 hours before any blood draw intended to assess liver status. This single step eliminates the muscular contamination signal from ALT and AST and makes the results genuinely interpretable.

Haematocrit and the Thrombosis Risk Curve

Testosterone and its derivatives stimulate erythropoiesis through two mechanisms: direct androgenic action on erythroid progenitor cells in bone marrow, and stimulation of erythropoietin (EPO) synthesis in the kidneys via the androgen receptor. The result is a dose-dependent rise in red cell mass that elevates whole-blood viscosity. Above a haematocrit of 52%, whole-blood viscosity begins increasing non-linearly; above 54%, the thrombotic risk becomes clinically significant, particularly under dehydration or during high-intensity exercise where blood flow dynamics are already stressed.

Management at 52–54%: reduce injectable dose, increase daily water intake to 3+ litres, add moderate cardiovascular exercise to support plasma volume. Above 54%, therapeutic phlebotomy of 450–500 mL is the most direct intervention and normalises haematocrit within days. Consistent haematocrit elevation despite dose reduction warrants evaluation for secondary polycythaemia through a haematologist.

Oestradiol: Symptom-Led Interpretation, Not Suppression

Oestradiol is not an adversary to be eliminated — it is a required signalling molecule. In men, oestradiol (primarily synthesised via aromatase/CYP19A1 conversion of testosterone in adipose and gonadal tissue) governs bone mineral density maintenance, HDL cholesterol regulation, cardiovascular endothelial function, libido, and synovial joint health. Suppressing it indiscriminately with aromatase inhibitors causes a well-characterised clinical syndrome: joint pain driven by loss of synovial fluid, erectile dysfunction, blunted libido, impaired mood, and accelerated bone turnover.

The functional target range for most males on cycle is 20–40 pg/mL, interpreted against symptoms rather than numbers alone. Oestradiol above 50–60 pg/mL with concurrent symptoms — fluid retention, nipple sensitivity, sustained elevated blood pressure — warrants a measured AI dose adjustment. Oestradiol below 15 pg/mL with dry joints, low libido, or depressed mood indicates AI overuse: reduce the inhibitor, do not increase testosterone dose in response.

Lipids, Orals, and Cardiovascular Risk Windows

Oral 17-alpha-alkylated androgens (oxandrolone, stanozolol, oxymetholone) suppress HDL cholesterol through hepatic lipase upregulation more aggressively than injectable esters, because first-pass hepatic metabolism concentrates the androgenic signal directly in liver tissue. HDL reductions of 40–70% from baseline over 6–8 weeks of oral use are documented in the literature. An HDL below 35 mg/dL represents a risk threshold that warrants shortening the oral phase or discontinuing it.

Mitigation strategy: omega-3 fatty acids at 2–4 g daily (EPA/DHA combined) provide modest HDL support and triglyceride reduction. Cardiovascular exercise at a minimum of 150 minutes per week of moderate-intensity aerobic work is the most effective lifestyle intervention for HDL maintenance. Lipids typically normalise within 4–8 weeks of stopping the offending compound; triglycerides recover faster than cholesterol fractions. Persistent dyslipidaemia beyond 12 weeks post-cycle warrants clinical lipid assessment.

FAQ

How do I get a full cycle blood panel in the UK without a GP referral?

Private preventive diagnostics companies and direct-access laboratory services across the UK allow self-referral bloodwork covering lipids, liver enzymes, full blood count, sex hormones, and gonadotropins. Many sports medicine practitioners will also run comprehensive panels. Online services post test kits and return results digitally. Costs vary; a full 12-marker panel typically runs between £60 and £120 depending on the provider and postage model.

Does prolactin testing only matter with nandrolone or trenbolone?

Prolactin monitoring is most clinically relevant with 19-nor compounds — nandrolone and trenbolone — because these bind the progesterone receptor (PGR) in addition to the androgen receptor, and elevated progesterone receptor signalling potentiates prolactin release. For straight testosterone-only cycles, prolactin elevation is uncommon unless oestradiol is significantly elevated, but including it in the baseline panel costs little and establishes an individual reference point.

How quickly does the HPG axis recover after a cycle?

Recovery timeline depends on cycle length, compound selection, and PCT protocol. LH and FSH typically begin rising within 2–4 weeks of all androgens clearing; total testosterone may take 8–16 weeks to return to individual baseline in a standard 12-week cycle. Longer cycles or those involving 19-nor compounds extend recovery timelines meaningfully. The post-PCT blood draw at 4–6 weeks is the only objective way to confirm recovery has actually occurred rather than assuming it.

Is blood pressure a blood test marker?

Blood pressure is not a laboratory value but is monitored on the same schedule as biochemical markers because AAS-driven haematocrit elevation, sodium retention, and direct androgenic effects on vascular smooth muscle all raise systolic and diastolic pressure. A systolic reading consistently above 140 mmHg on cycle requires the same urgency as a haematocrit above 54%. A validated upper-arm cuff device, measured at rest after five minutes seated, is the appropriate tool.

Can someone on TRT skip regular blood monitoring?

Testosterone replacement therapy is a continuous, indefinite intervention — monitoring is proportionally more important, not less. Haematocrit, PSA (in males over 40 or with family history), and lipid fractions should be assessed at minimum every six months. Haematocrit elevation is as common on TRT doses as on performance doses in individuals who are responders to erythropoietic stimulation, and thrombotic risk does not distinguish between therapeutic intent and performance intent.

Conclusion

Twelve markers, four blood draws, and clear numerical thresholds — that is the complete monitoring framework for a responsible anabolic cycle. Haematocrit and haemoglobin protect against thrombosis; lipid fractions define cardiovascular risk exposure; GGT provides an honest hepatic signal; and the hormonal markers — oestradiol, testosterone, LH, FSH — reveal both on-cycle management requirements and post-cycle axis recovery. None of these parameters produce reliable symptoms until they reach damaging levels, which is precisely what makes laboratory monitoring non-optional rather than merely advisable. The data exists to run cycles with open eyes — the only question is whether you choose to look.

This article is published for harm reduction and educational purposes and does not constitute medical advice. Reference ranges vary between laboratories. Consult a qualified healthcare professional before making any changes to medication or supplementation.